PremalDilipLullaMD

Hematologic Oncology

Physician

Dr. Lulla is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
1 Baylor Plz
Dept. Of Internal Medicine
Houston, TX 77030
Phone+1 713-798-0190

Baylor College of MedicineFellowship, Hematology and Medical Oncology, 2012 - 2015
Baylor College of MedicineResidency, Internal Medicine, 2009 - 2012
Dr. DY Patil Medical CollegeClass of 2008

Multiple Myeloma Trial of Orally Administered Salmonella Based Survivin Vaccine Start of enrollment: 2021 Aug 06
Active, not recruiting
Phase 1
Anti-SARS Cov-2 T Cell Infusions for COVID 19 Start of enrollment: 2020 Nov 04
Terminated
Phase 1
STRIDE Biorepository Start of enrollment: 2017 Mar 13
Recruiting
Roles: Contact
Administration of Donor Multi TAA-Specific T Cells for AML or MDS (ADSPAM) Start of enrollment: 2016 Feb 01
Recruiting
Phase 1
Roles: Principal Investigator, Contact
MM CAR-T to Upgrade Response BMTCTN1902 Start of enrollment: 2022 Jan 05
Active, not recruiting
Phase 2
Roles: Contact
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma Start of enrollment: 2015 Apr 01
Recruiting
Phase 1
Roles: Contact, Principal Investigator
Allogeneic CD30 Chimeric Antigen Receptor Epstein-Barr Virus-Specific T Lymphocytes in Relapsed or Refractory CD30-Positive Lymphomas Start of enrollment: 2024 Mar 01
Withdrawn
Phase 1
Roles: Contact, Principal Investigator
Constitutive IL7R (C7R) Modified Banked Allogeneic CD30.CAR EBVSTS for CD30-Positive Lymphomas Start of enrollment: 2024 Jun 01
Not yet recruiting
Phase 1
Roles: Contact, Principal Investigator
Join now to see all

PubMed

203 citations
Anti-CD30 CAR-T Cell Therapy in Relapsed and Refractory Hodgkin Lymphoma.
Carlos A. Ramos, Natalie S Grover, Anne W. Beaven, Premal Lulla, Meng Fen Wu
Journal of Clinical Oncology. 2020-07-23
302 citations
Off-the-Shelf Virus-Specific T Cells to Treat BK Virus, Human Herpesvirus 6, Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections After Allogeneic Hematopoie...
Ifigeneia Tzannou, Anastasia Papadopoulou, Swati Naik, Kathryn Leung, Caridad Martinez
Journal of Clinical Oncology. 2017-08-07
93 citations
CD7 CAR T Cells for the Therapy of Acute Myeloid Leukemia.
Diogo Gomes-Silva, Erden Atilla, Pinar Ataca Atilla, Feiyan Mo, Haruko Tashiro
Molecular Therapy. 2019-01-02

Baylor Awarded CPRIT Grants for Cancer Research and Prevention ProgramsAugust 20th, 2020
An Early Look at When CAR-T Therapy Fails Patients with CLLMarch 10th, 2020